LONDON, Jan. 18, 2016 /PRNewswire/ -- Biotechnology as an industry has been around for many years now. The manipulation of biological processes is nothing new as the fermenting of grains and fruits to create alcoholic beverages to the discovery of penicillin has been around since the 1920s. Advances in genomics, molecular biology and computing power has made it possible for the field of biotechnology to advance and develop more targeted medicines, manufacture high nutrition crops, and even manufacture grow artificial organs and tissues.
Following the economic recession of 2008-2009,
has been growing at a strong rate, despite a slowdown in 2013. However, forecast for the global biotech industry is expected to show strong growth till the year 2019.
Emerging markets like China, Brazil and India are leading the sales in the global biotechnology market. The Americas and Europe regions hold the biggest share in the global biotechnology industry - Americas had a share of nearly 45%, followed by Europe accounting for nearly 30% of the global biotechnology industry. The medical/healthcare segment is the leading segment of the biotechnology industry and in 2014 it consisted of nearly 60% of the global biotech industry's total value. This was followed by the food and agriculture segment.
Aruvian Research analyzes the Global Biotechnology Industry in this comprehensive research report. Analyzing the Global Biotechnology Industry covers the biotech market from the year 2010 till 2019. The report analyzes a total of 23 biotech markets and over 40 biotech companies.
The report begins with an analysis of the global biotechnology industry through industry statistics, industry value analysis and an industry segmentation. We segment the global biotech industry into bioinformatics, genomics, pharmacogenomics and proteomics. We also analyze industry financing and investments. Forecast for the global biotechnology industry is included till 2019. An industry definition precedes this section.
The Global Biotechnology Industry is analyzed through Porter's Five Forces Strategy Analysis. We look at the biotech industry through buyer and supplier power, competitive rivalry in the industry, threat of new entrants and the threat of substitutes.
The blurring differences between biotech and pharma companies is analyzed in our report.
Moving on, we analyze market trends and challenges facing the global biotechnology industry such as the emergence of bioinformatics, biosensor technology, cloning technology, and others. Challenges facing the industry are analyzed such as industry globalization, intellectual property issues, regulatory barriers, lack of investor confidence, financial issues, issues with genetic manipulation, and lack of adequate water, amongst a host of other barriers are all analyzed.
Moving to the analysis of the 23 key biotech markets, we analyze each country through industry statistics, industry value analysis, industry segmentation and forecast till 2019. Countries analyzed include Belgium, Canada, China, France, Germany, Italy, Japan, Netherlands, Spain, United Kingdom and United States. Other markets we analyze briefly include Australia, Brazil, Cuba, Malaysia, New Zealand, Pakistan, Romania, Singapore, South Korea, Sri Lanka, Switzerland and Tanzania.
Major players in the global biotech industry are analyzed through a corporate profile, an analysis of the business segments they operate through, a company strategy wherever available, financial analysis and a SWOT analysis. We analyze a total of 44 companies in the report.
The report Analyzing the Global Biotechnology Industry is ideal for investors, competitors within the industry, as well as companies looking to enter the global biotech market will find this report to be meaningful in understanding the workings of the industry.
Download the full report:
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers